# Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

> **NCT00001531** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 355 (—)

## Conditions studied

- Arterial Occlusive Diseases
- Atherosclerosis
- Coronary Disease
- Cytomegalovirus Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00001531
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1996-06
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 355 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001531, "Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*